Dirk Kuyper, president and CEO of Alphatec Spine, attributes the company’s success to its focus on expanded research and development efforts, particularly in developments for aging spine, minimally invasive surgery and biologics.
Domestic revenues for 4Q 2010 were $32.1 million, an increase of 13.5 percent from the $28.3 million reported for 4Q 2009. Additionally, international revenues for 4Q 2010 were $13.9 million, an increase of $8.9 million from the $5 million reported for 4Q 2009.
During the fourth quarter, the company acquired Scient’x subsidiaries, which accounts for $6.8 million of the total $332 million reported expenses.
Read the news release about Alphatec Spine’s 4Q results.
Read other coverage about Alphatec Spine:
– Alphatec Spine Signs Agreement With Merlot OrthopediX for Spine Surgery Technology
– Alphatec Spine Reports 3Q Net Revenue of $44M, 49% Increase
– Alphatec Holdings Announces 19.4% Growth in U.S. Spine Market for Q1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
